Wilson HTM have upgraded to a Buy saying that there is modest sales upside to current market in salvage therapy and that the company trades at 8.0x EV/EBITDA which is half the multiple to its peers
https://login.wilsonsadvisory.com.a...-sirtexs-50-discount-versus-medtech-peers.pdf
Add to My Watchlist
What is My Watchlist?